GT
PRNB

Glenmede Trust’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Glenmede Trust’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-30
Closed -$3K – 2570
2020
Q3 		$3K Sell
30
-16
-35% -$1.42K ﹤0.01% 2233
2020
Q2 		$2K Buy
+46
New +$2.84K ﹤0.01% 2301

Glenmede Trust's PRNB Position: Q4 2020 in Review

Glenmede Trust sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q4 2020, closing a stake of 30 shares — an estimated $3K sold.

Glenmede Trust first reported a position in PRNB in Q2 2020 and held it in 2 quarters. The position peaked at $3K in Q3 2020. 0 funds tracked by Wall St. Rank hold PRNB as of Q4 2020.

  • Glenmede Trust reported no remaining Principia Biopharma Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 30 Principia Biopharma Inc. Common Stock shares in Q4 2020, an estimated $3K.
  • Glenmede Trust first reported a position in Principia Biopharma Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Glenmede Trust's Principia Biopharma Inc. Common Stock position peaked at $3K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.